Phase II trial of neoadjuvant mFOLFOX 6 with panitumumab (P) in T3 rectal cancer with clear mesorectal fascia (MRF) and KRAS, NRAS, BRAF, PI3KCA wild type (4WT). GEMCAD 1601 PIER trial. - Fernandez-Martos, Carlos; Pericay, Carles; Maurel, Joan; Virgili, Ana; Capdevila, Jaume; Gallego, Javier; Vera, Ruth; Rodriguez-Salas, Nuria; Losa, Ferran; Valladares, Manuel; Vivancos, Ana; Ayuso, Juan; et al. (JOURNAL OF CLINICAL ONCOLOGY, 2021)